Algorithm of treatment of patients with pulmonary sarcoidosis

Abstract

Objective — to develop the algorithm of treatment of patients with pulmonary sarcoidosis, based on the data regar­ding the rate of contraindications, adverse reactions and resistance to glucocorticosteroids (GCS) and the choice of the optimal drug for immunosuppressive therapy. Materials and methods. The study involved 185 patients with newly diagnosed lung parenchyma sarcoidosis to investigate the rate of contraindications, adverse reactions and resistance to GCS was conducted. The comparative study of azathioprine, leflunomide and methotrexate efficacy was performed in 43 pulmonary sarcoidosis patients. Results and discussion. At average, every eighth patient with stage II—III pulmonary sarcoidosis (12.4 %) required the administration of immunosuppressive therapy immediately after the diagnosis established due to contraindications for GCS use. During the course of GCS treatment, the necessity to use immunosuppressive drugs increases due to development of serious side effects or resistance in up to 32.4 % of patients. That is, every third patient in different phases of treatment would require immunosuppressant drugs. In majority of patients with GSC contraindications/serious side effects, an alternative therapy with azathioprine 50 mg/day with subsequent elevation of daily dose on 25 mg/day every 2 weeks (until maximum dose reached) was not effective. The use of leflunomide (20 mg/day) increased the rate of regression of sarcoidosis after 3 months of the therapy by 50 %. Unlike azathioprine and leflunomide, methotrexate (10 mg/week) was effective in the most part of patients (73,7 %). Methotrexate had more favorable safety profile. In comparison with azathioprine and leflunomide there were no serious side effects registered during 3 months of therapy with methotrexate (10 mg/week). Conclusions. An algorithm of therapy of patients with sarcoidosis has been created, based on the taking into account the contraindications, adverse reactions and resistance to GCS and the use of methotrexate as immunosuppressive medication with optimal efficacy and safety properties.

Authors and Affiliations

V. K. Gavrysyuk, E. О. Merenkova, G. L. Gumeniuk, O. V. Bychenko

Keywords

Related Articles

The mebicar efficacy in correction of the psycho-emotional background in patients with stable ischemic heart disease with permanent atrial fibrillation

Objective — to assess the dynamics of the psycho-emotional background under the influence of adminitrsation of the anxiolytic drug mebicar. Materials and methods. The observations were performed in 31 patients with stabl...

Relationship between vaspin, TNF-α and parameters of carbohydrate metabolism in patients with type 2 diabetes mellitus

Objective — to assess the vaspin and TNF-α levels in patients with type 2 diabetes mellitus (DM-2), depending on the parameters of carbohydrate metabolism. Materials and methods. Examinations involved 31 patients with DM...

Platelet and coagulation hemostasis in conditions of the combined cardiac and gallbladder disorders

The changes in cardiac function resulting from the gallbladder (GB) disorders are known as a cholecystocardial syndrome. The complexity of its pathogenesis can be explained by simultaneous effects of several mechanisms (...

Labial herpes: view on the problem, options for optimizing topical therapy

Herpes virus infection holds a special place in the structure of viral diseases due to its high prevalence in the population, a variety of clinical forms, as well as the steadily growing number of infected people. Labial...

Report on the work of the Expert Problem Commission "Therapy" of the Ministry of Health and Science of Ukraine for the 2nd half of 2017

During the reporting period, the Expert Problem Commission (EPC) received materials on the planning of 3 candidate dissertations, the approval of 5 scientific papers, 6 informative letters, 4 methodical recommendations a...

Download PDF file
  • EP ID EP276354
  • DOI -
  • Views 147
  • Downloads 0

How To Cite

V. K. Gavrysyuk, E. О. Merenkova, G. L. Gumeniuk, O. V. Bychenko (2018). Algorithm of treatment of patients with pulmonary sarcoidosis. Український терапевтичний журнал, 0(1), 39-45. https://europub.co.uk/articles/-A-276354